[Guest Post] COVID-19: The Invisible Enemy Revisited
This post was first published on The IPKat blog:
In 2009, Mexico battled an outbreak of a new strain of influenza, the AH1N1 disease, also known as swine flu. The first symptoms appeared in the country at the beginning of April 2009 and, sometime thereafter, two already marketed medicines indicated for influenza, TAMIFLU® (OSELTAMIVIR) and RELENZA® (ZANAMIVIR), were found to be effective against the disease. The government imposed tight measures across the country. Millions of face masks were handed out to citizens and Mexico City carried out a 10-day quarantine.
The IPKat recently reported, here, on taken measures by the Israeli government to order the equivalent of a compulsory license to enable local companies to make use of the inventions in the search for effective treatment of the COVID-19 virus. Kat friends Alejandro Luna and Portia Guidotti (Olivares) consider how Mexico successfully controlled a pandemic virus in the past, without the need for compulsory licenses.
In 2009, Mexico battled an outbreak of a new strain of influenza, the AH1N1 disease, also known as swine flu. The first symptoms appeared in the country at the beginning of April 2009 and, sometime thereafter, two already marketed medicines indicated for influenza, TAMIFLU® (OSELTAMIVIR) and RELENZA® (ZANAMIVIR), were found to be effective against the disease. The government imposed tight measures across the country. Millions of face masks were handed out to citizens and Mexico City carried out a 10-day quarantine. 
![[Nuevo libro] Ley Federal de Protección a la Propiedad Industrial comentada por AMPPI](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEg3r-BhqtSWMnCSTS1yp64_EUvxe0z-y7XXKOUcYpUrsnN3CI5sGkVKGdkhrCEXx4FXnp1LeZEQfrpXypLmLoMd7s7qfixS1383NjHxi-8Rf8UpLCZiaZ8mrY4AFxxVLXssYs6N4L-OTomTUwyG7rCC76ASCC3AZiBqlJYjIeQXvqo4evPFt_9Ny7SRbk8/s72-c/LFPPI%20%20Tirant.jpg)
